Public Policy
Another Day, Another Opioid Lawsuit
Meanwhile , the healthcare field continues to struggle with legitimate issues around the use of (and controls over) opioids in medical practice.
Topics: opioids
Raising the Tobacco Age Limit
So, public health advocates maintain, the McConnell plan is really just a clever ruse to reduce support for other legislation that might actually reduce smoking and vaping.
Topics: prevention, tobacco, vaping
Proposing a Plan
This is in part a course correction from the trend of several decades ago, when the emphasis was on cutting expenses in the naive belief all addicts could be successfully treated on an outpatient basis.
Topics: recovery-friendly, systems
Coercion in Massachusetts
I compare it to finding someone lying on the sidewalk, helping them up, brushing them off, and pushing them down again.
Topics: consequences, court-mandated, leverage, opioids
Treatment and Coercion
Those of us who work in treatment quickly sense a problem: people with addictions aren’t likely to respond to this approach.
Topics: consequences, criminal courts, leverage
The New Herbalists
Unbeknownst to the patient, the CBD products they also use could affect how well those prescribed medicines work, or interact with them in unhelpful ways.
Topics: cannabis, prescription medications
Buyer Beware
…in many instance, it’ll be an unfair fight between enormously well-funded, politically savvy industry lobbies and a few determined nonprofits that advocate for public health.
Topics: advocacy
A Price We Can Afford
Investors naturally seek to increase the value of their investment, while patients seek access to medication they need at a price they can afford.
Topics: prescription medications
Debate About New Painkillers
I can imagine a hundred scenarios in which Dsuvia somehow leaves the battlefield and finds it way into the world of drug abuse.
Topics: opioids, prescription medications